RBB Economics provides independent, expert economic advice on all aspects of competition law. We combine intellectual rigour with practical knowledge and technical economic skills to deliver analysis that is robust, clear and effective.
‘We had regular contact with the RBB consultants on our case. They were always available, supportive and responsive to our needs. Everyone we dealt with was professional, friendly and totally committed to our case.’— International Airlines Group
‘They were thorough, professional and hugely supportive throughout the entire process and we have happily worked with them on many occasions, including the important Art. 102 investigation.’— Google
‘RBB deliver expert advice in a timely manner. What’s more, they don’t try to blind us with science — whilst sophisticated, detailed, and comprehensive, all of their analysis remains also accessible, clear and straightforward.’— General Electric
‘The RBB team thoroughly immersed themselves in our business to understand the real-world dynamics of competition. As a result, they were able to provide us with innovative, bespoke analysis to support our case.’— BHP Billiton
'RBB's economists are proactive, rigorous and extremely professional. Their detailed economic analysis was a key factor in convincing the Commission to dismiss its initial concerns and clear our proposed acquisition of Sun in 2010.'— Oracle
RBB Economics provides independent, expert economic advice on all aspects of competition law.
We combine intellectual rigour with practical knowledge and technical economic skills to deliver analysis that is robust, clear and effective.
No Penalty for TasPorts in the ACCC’s first case under the new misuse of market power test
TasPorts is the owner and operator of the majority of ports in Tasmania, and the sole supplier of towage and pilotage services at all major ports on the island. In its Concise Statement to the Federal Court of Australia, the ACCC alleged...
Read more (May 2021)
The EC clears EssilorLuxottica/GrandVision, subject to conditions
The European Commission has conditionally approved EssilorLuxottica’s acquisition of GrandVision, after a Phase II review. EssilorLuxottica is a global manufacturer of spectacle frames, sunglasses, and ophthalmic lenses, and it owns...
Read more (March 2021)
Siemens Healthineers’ acquisition of Varian Medical Systems cleared in Phase I subject to conditions
On 19 February, the European Commission (“EC”) approved Siemens Healthineers’ acquisition of Varian Medical Systems following a Phase I investigation subject to conditions. Varian is one of the leading suppliers of radiation...
Read more (February 2021)